NEW YORK, Jan. 26 /PRNewswire/ -- Strategic Research Institute is pleased to announce the upcoming Patient Level Data conference scheduled to take place on April 4-5, 2006 in New Brunswick, NJ. An agenda fully-loaded with big pharma participants, this conference offers the opportunity to understand & learn about the most effective best practices and reap the benefits on adopting this new strategic tool. In sum, PLD accelerates pharma marketers strategic decision making and marketing effectiveness which gives them the clear edge on conquering untapped market potential.
The future direction of PLD and how its impact affects the other elements of the marketing mix will be reflected upon the latest sessions on:
1) Privacy laws and how they affect PLD, Jessica Blazer, Senior Attorney, Privacy Office, WYETH PHARMACEUTICALS; Hilary Wandall, Director, Corporate Legal/Merck Privacy Office, MERCK & CO., INC. 2) Opted-in patient level data, Jim Hoch, Independent Consultant, ACCESS BIOTECH; Carl V. Asche, Ph.D., Research Associate Professor, Department of Pharmacotherapy, UNIVERSITY OF UTAH COLLEGE OF PHARMACY 3) Big Pharma's views on longitudinal data, Mohan Bala, Director, Outcomes Research, CENTOCOR; Vladimir Castillo, Associate Director of Database Marketing & Analytics, BRISTOL-MYERS SQUIBB; Moreshwar Deshpande, Manager, Forecasting, AMGEN; Anshuman Panigrahi, Manager, Management Science Business, NOVARTIS PHARMACEUTICALS 4) Opportunities to improve and enhance PLD- pharma & partner interactive panel, Charley Beever, Vice President, BOOZ ALLEN HAMILTON; Barbara Edelman Lewis, Ph.D., MHA, Director, Health Economics and Outcomes Research, ASTRAZENECA; Jesse Ma, Team Leader Local Market Optimization & Decision Support, ELI LILLY & COMPANY; Ganesh Vedarajan, Principal, ZS ASSOCIATES
The conference features presenters from the industry from large, medium and small pharmaceutical manufacturers of marketing information. The complete list of presenters includes: Amgen, Amylin Pharmaceuticals, AstraZeneca, Bristol-Myers Squibb, Centocor, Inc., Coley, Daiichi, Elan Pharmaceuticals, Eli Lilly & Company, Genzyme Corporation, GlaxoSmithKline, Indevus, Johnson & Johnson, King Pharmaceuticals, MedImmune, Merck & Co., Ortho-McNeil Janssen Pharma, Pfizer, Inc., Millennium Pharmaceuticals, Novartis, Sankyo, Sanofi-Aventis, Serono, Solvay Pharmaceuticals, Vertex Pharmaceuticals and Wyeth.
This event will be part of the Pharmaceutical Marketing Summit (PMS), a 6-conference shared opening session that features high-level executive panels on some of the most press marketing topics, namely, strategic marketing, branding, emerging and mid-sized company marketing challenges, managed cared/MMA, and global marketing. The conference website is www.srinstitute.com/pms.
400-600 high-level Pharma delegates are expected to attend the larger PMS; PLD delegates will be permitted to attend sessions from all concurrent meetings during its duration as well as the socializing and networking events, and nightly entertainment planned to facilitate speaker and attendee mixing.
A special rate for pharmaceutical company executive delegates has been implemented for the all 6 conferences and all delegates may benefit from registering early on and in groups for the greatest saving.
To request the Patient-Level Data agenda in PDF, contact Ed Drilon, the organizer and Vice President of Life Sciences at Strategic Research Institute at edrilon@srinstitute.com.
Sponsors and exhibitors are urged to book space early for best booth placement. Space is allocated on a first-come, first-serve basis, and features space up to 10 x 10, passes to all the sessions and events and other benefits. Join lead sponsors PDI, Inc and Campbell Alliance for even greater exposure through a variety of other options all of which provide for optional booth space and passes. Contact Mark Alexay at malexay@srinstitute.com or 212.967.0095, extension 251 to determine what level of exposure works best for you.
To become a media partner, please contact Cheryl Kahan-Radhuber at ckahan-radhuber@srinstitute.com.
Strategic Research InstituteCONTACT: Mark Alexay, +1-212-967-0095, ext. 251, ormalexay@srinstitute.com
